Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03889795 · ClinicalTrials.gov registry record · Phase 1

Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors

A Phase 1 study of Advanced Solid Tumor and Advanced Pancreatic Cancer, sponsored by Danae Hamouda, MD.

Active
Registry status
Phase 1
Development phase
15
Enrollment target
1
Study location

NCT03889795 is a Phase 1 study of Advanced Solid Tumor and Advanced Pancreatic Cancer that is active but no longer recruiting, run by Danae Hamouda, MD. The registered enrollment target is 15 participants, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03889795, a Phase 1 study of Advanced Solid Tumor and Advanced Pancreatic Cancer, is active but no longer recruiting, sponsored by Danae Hamouda, MD.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This is a single-center trial in subjects with pancreatic cancer and other advanced solid tumors. It is an open-label, single arm dose escalation Phase IB trial with subjects accrued in a 3 subject dose escalation cohort. Subjects with treated advanced solid tumors, and showing disease progression on established standard therapy, will be enrolled in this trial.

Conditions Studied

Advanced Solid Tumor Advanced Pancreatic Cancer

Interventions

  • DRUG Metformin
  • DRUG Simvastatin
  • DRUG Digoxin

Study Locations (1)

Ohio

  • University of Toledo, Eleanor N. Dana Cancer Center - Toledo

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2019-06-05
Est. Completion 2027-12-30
Phase Phase 1

Sponsor

Danae Hamouda, MD

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03889795

The ClinicalTrials.gov registry entry for NCT03889795 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (92% lower). The listed sponsor is Danae Hamouda, MD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Advanced Solid Tumor appearing as the primary indexed condition, and to 3 interventions - of which Metformin is the first listed.

NCT03889795 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT03889795 about?

NCT03889795 is a clinical study titled "Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors". This is a single-center trial in subjects with pancreatic cancer and other advanced solid tumors. It is an open-label, single arm dose escalation Phase IB trial with subjects accrued in a 3 subject dose escalation cohort. Subjects with treated advanced solid tumors, and showing disease progression o...

What is the current status of trial NCT03889795?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2019-06-05. Estimated completion is 2027-12-30.

What conditions does trial NCT03889795 study?

This clinical trial studies the following conditions: Advanced Solid Tumor, Advanced Pancreatic Cancer.

What interventions are being tested in trial NCT03889795?

The interventions under investigation include: Metformin (DRUG), Simvastatin (DRUG), Digoxin (DRUG).

Who is sponsoring clinical trial NCT03889795?

This trial is sponsored by Danae Hamouda, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03889795 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumor

All registered trials for this condition

Advanced Pancreatic Cancer

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.